发明名称 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
摘要 The invention relates to compounds of the formula I in which R1 to R9 are as defined herein. In one embodiment, these compounds may be used as antihypertensives, for reducing or preventing ischemia-induced damage, as medicaments for surgical intervention for the treatment of ischemias of the nervous system, of stroke and of cerebral edema, of shock, of impaired respiratory drive, for the treatment of snoring, as laxative, as agent against ectoparasites, to prevent the formation of gallstones, as antiatherosclerotics, agents against late complications of diabetes, cancers, fibrotic disorders, endothelial dysfunction, organ hypertrophies and hyperplasias. In one embodiment, the compounds may be inhibitors of the cellular sodium-proton antiporter and influence serum lipoproteins and thus be used for the prophylaxis and for the regression of atherosclerotic lesions.
申请公布号 US6911453(B2) 申请公布日期 2005.06.28
申请号 US20020309352 申请日期 2002.12.04
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH 发明人 HOFMEISTER ARMIN;HEINELT UWE;LANG HANS-JOCHEN;BLEICH MARKUS;WIRTH KLAUS;GEKLE MICHAEL
分类号 C07D217/18;C07D401/12;C07D405/12;C07D409/12;C07D417/12;(IPC1-7):C07D217/00;A61K31/47 主分类号 C07D217/18
代理机构 代理人
主权项
地址